Previous studies identified TXNRD1 as a regulator of endocellular oxidative stress and a promoter of tumor development [23, 24], with irreversible suppression of cytoplasmic TXNRD1 levels demonstrated as a novel direction for cancer treatment [11, 25, 26]. The gene discussed is TXNRD1; the disease is neoplasm.